Saturnino Haya
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Predicting Thrombophilia in Preeclampsia: Is Universal Testing Necessary?
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: April 13, 2025
Patient-Centred Management of Well-Controlled Haemophilia: Obtaining Opinions and Definitions Through a Delphi Consensus.
Journal: Journal of clinical medicine
Published: February 10, 2025
Efficacy and safety evaluation of Fanhdi® , a plasma-derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 28, 2021
Management of acquired hemophilia A: results from the Spanish registry.
Journal: Blood advances
Published: March 01, 2021
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients.
Journal: Thrombosis research
Published: January 21, 2021
Factor XIII deficiency in two Spanish families with a novel variant in gene F13A1 detected by next-generation sequencing; symptoms and clinical management.
Journal: Journal of thrombosis and thrombolysis
Published: February 16, 2020
Prophylactic treatment in hemophilic patients with inhibitors.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: September 14, 2019
Next generation sequencing in bleeding disorders: two novel variants in the F5 gene (Valencia-1 and Valencia-2) associated with mild factor V deficiency.
Journal: Journal of thrombosis and thrombolysis
Published: July 04, 2019
Clinical and molecular characterization by next generation sequencing of Spanish patients affected by congenital deficiencies of fibrinogen.
Journal: Thrombosis research
Published: April 12, 2019
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate® ) and BAY 81-8973 (Kovaltry® ) in patients with severe or moderate haemophilia A in prophylaxis.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 18, 2019
Predictive factors of immune tolerance treatment response in severe haemophilia A patients with inhibitors: A real-world report from a single centre, mixed retrospective-prospective long-term study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 04, 2019
The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 17, 2018
Last Updated: 09/26/2026